Although the company reported $0.05 EPS and $0.36M in quarterly revenue, it shows weak profitability (negative return on equity and an extremely negative net margin), indicating continued financial stress.
Hyperion DeFi, Inc. (NASDAQ:HYPD – Get Free Report) Director Michael Geltzeiler acquired 30,000 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was bought at an average price of $3.01 per share, with a total value of $90,300.00. Following the purchase, the director directly owned 88,015 shares of the company’s stock, valued at $264,925.15. This represents a 51.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Hyperion DeFi Stock Performance
Shares of HYPD stock opened at $3.67 on Friday. The stock’s 50-day moving average is $5.31 and its two-hundred day moving average is $7.51. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.25 and a current ratio of 2.25. Hyperion DeFi, Inc. has a 1 year low of $0.85 and a 1 year high of $17.99. The firm has a market cap of $29.98 million, a price-to-earnings ratio of -0.91 and a beta of 2.80.
Hyperion DeFi (NASDAQ:HYPD – Get Free Report) last announced its earnings results on Friday, November 14th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.36 million during the quarter. Hyperion DeFi had a negative return on equity of 119.59% and a negative net margin of 62,238.41%. Analysts predict that Hyperion DeFi, Inc. will post -41.6 earnings per share for the current year.
Wall Street Analyst Weigh In
HYPD has been the topic of a number of recent research reports. Wall Street Zen raised shares of Hyperion DeFi from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Cantor Fitzgerald started coverage on shares of Hyperion DeFi in a research report on Tuesday. They set an “overweight” rating and a $4.00 price objective on the stock. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Hyperion DeFi in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Hyperion DeFi currently has an average rating of “Hold” and an average target price of $3.00.
Get Our Latest Stock Report on HYPD
Hyperion DeFi Company Profile (
Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company’s product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
Read more on InsiderTrades.com
